Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.
O'Neill AF, Trobaugh-Lotrario A, Geller JI, Hiyama E, Watanabe K, Aerts I, Fresneau B, Toutain F, Sullivan MJ, Katzenstein HM, Morland B, Branchereau S, Zsiros J, Maibach R, Ansari M. O'Neill AF, et al. Among authors: aerts i. EClinicalMedicine. 2024 Feb 15;69:102446. doi: 10.1016/j.eclinm.2024.102446. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384339 Free PMC article. Review.
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.
Hargrave DR, Terashima K, Hara J, Kordes UR, Upadhyaya SA, Sahm F, Bouffet E, Packer RJ, Witt O, Sandalic L, Kieloch A, Russo M, Cohen KJ; Investigators involved in the high-grade glioma cohort. Hargrave DR, et al. J Clin Oncol. 2023 Nov 20;41(33):5174-5183. doi: 10.1200/JCO.23.00558. Epub 2023 Aug 29. J Clin Oncol. 2023. PMID: 37643378 Clinical Trial.
MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma.
de Bloeme CM, van Elst S, Galluzzi P, Jansen RW, de Haan J, Göricke S, Moll AC, Bot JCJ, Munier FL, Beck-Popovic M, Puccinelli F, Aerts I, Hadjistilianou T, Sirin S, Koob M, Brisse HJ, Cardoen L, Maeder P, de Jong MC, de Graaf P. de Bloeme CM, et al. Among authors: aerts i. Cancers (Basel). 2024 May 16;16(10):1899. doi: 10.3390/cancers16101899. Cancers (Basel). 2024. PMID: 38791976 Free PMC article.
Sequential analysis of cfDNA reveals clonal evolution in neuroblastoma patients receiving ALK targeted therapy.
Bobin C, Iddir Y, Butterworth C, Masliah-Planchon J, Saint-Charles A, Bellini A, Bhalshankar J, Pierron G, Combaret V, Attignon V, André N, Corradini N, Dumont B, Mansuy L, Khanfar C, Klein S, Briandet C, Plantaz D, Millot F, Thouvenin S, Aerts I, Ndounga-Diakou LA, Laghouati S, Abbou S, Jehanno N, Tissot H, Renault S, Baulande S, Raynal V, Bozec L, Bieche I, Delattre O, Berlanga P, Schleiermacher G. Bobin C, et al. Among authors: aerts i. Clin Cancer Res. 2024 May 24. doi: 10.1158/1078-0432.CCR-24-0753. Online ahead of print. Clin Cancer Res. 2024. PMID: 38787533
FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
de Traux De Wardin H, Cyrta J, Dermawan JK, Guillemot D, Orbach D, Aerts I, Pierron G, Antonescu CR. de Traux De Wardin H, et al. Among authors: aerts i. Genes Chromosomes Cancer. 2024 Apr;63(4):e23232. doi: 10.1002/gcc.23232. Genes Chromosomes Cancer. 2024. PMID: 38607246 Review.
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
Roehrig A, Hirsch TZ, Pire A, Morcrette G, Gupta B, Marcaillou C, Imbeaud S, Chardot C, Gonzales E, Jacquemin E, Sekiguchi M, Takita J, Nagae G, Hiyama E, Guérin F, Fabre M, Aerts I, Taque S, Laithier V, Branchereau S, Guettier C, Brugières L, Fresneau B, Zucman-Rossi J, Letouzé E. Roehrig A, et al. Among authors: aerts i. Nat Commun. 2024 Apr 8;15(1):3031. doi: 10.1038/s41467-024-47280-x. Nat Commun. 2024. PMID: 38589411 Free PMC article.
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?
Raiser P, Schleiermacher G, Gambart M, Dumont B, Defachelles AS, Thebaud E, Tandonnet J, Pasqualini C, Proust S, Entz-Werle N, Aerts I, Ndounga-Diakou LA, Petit A, Puiseux C, Khanfar C, Rouger J, Mansuy L, Benadiba J, Millot F, Pluchart C, Laghouati S, Geoerger B, Vassal G, Valteau-Couanet D, Berlanga P. Raiser P, et al. Among authors: aerts i. Eur J Cancer. 2024 May;202:114001. doi: 10.1016/j.ejca.2024.114001. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489858 Free article.
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
Pire A, Hirsch TZ, Morcrette G, Imbeaud S, Gupta B, Pilet J, Cornet M, Fabre M, Guettier C, Branchereau S, Brugières L, Guerin F, Laithier V, Coze C, Nagae G, Hiyama E, Laurent-Puig P, Rebouissou S, Sarnacki S, Chardot C, Capito C, Faure-Conter C, Aerts I, Taque S, Fresneau B, Zucman-Rossi J. Pire A, et al. Among authors: aerts i. Eur J Cancer. 2024 Mar;200:113583. doi: 10.1016/j.ejca.2024.113583. Epub 2024 Feb 1. Eur J Cancer. 2024. PMID: 38330765 Free article.
Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study.
Charrier T, Haddy N, Schwartz B, Journy N, Fresneau B, Demoor-Goldschmidt C, Diallo I, Surun A, Aerts I, Doz F, Souchard V, Vu-Bezin G, Laprie A, Lemler S, Letort V, Rubino C, Chounta S, de Vathaire F, Latouche A, Allodji RS. Charrier T, et al. Among authors: aerts i. JACC CardioOncol. 2023 Oct 3;5(6):792-803. doi: 10.1016/j.jaccao.2023.07.008. eCollection 2023 Dec. JACC CardioOncol. 2023. PMID: 38205003 Free PMC article.
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
André N, Deley MCL, Léguillette C, Probst A, Willems L, Travers R, Aerts I, Faure-Conter C, Revond-Riviere G, Min V, Geoerger B, Chastagner P, Entz-Werlé N, Leblond P. André N, et al. Among authors: aerts i. Eur J Cancer. 2024 Feb;198:113525. doi: 10.1016/j.ejca.2024.113525. Epub 2024 Jan 6. Eur J Cancer. 2024. PMID: 38199147 Free article. Clinical Trial.
134 results